MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1177/02676591261460654

Медицинская библиотека · Perfusion · 2026

Safety and efficacy of transcatheter aortic valve replacement (TAVR) vs. surgical aortic valve replacement (SAVR) in patients with bicuspid aortic stenosis: A Systematic review and meta-analysis.

Gadelmawla Ahmed Farid, Mansour Ahmed, Elbataa Ahmed, Asiri Osama Hamdi, Alharbi Amnah Ali, Alquraish Fatimah Ashraf, Al-Ibrahim Fatem Saleh, AlHasani Abdulaziz Fahad, Alharbi Turki Nashi, Al Murayyi Ruba Mohammed, Alotaibi Abdulelah Ghazi, Abdul-Hafez Hamza A, Suliman Ihab

СтатьяОбзорПеревод в очереди

Аннотация

BackgroundBicuspid aortic valve (BAV) disease is a leading cause of aortic stenosis (AS). Surgical aortic valve replacement (SAVR) has traditionally been regarded as the best therapeutic option for bicuspid AS. However, the distinctive anatomical characteristics of BAV make the treatment with transcatheter aortic valve replacement (TAVR) challenging, so this population was often excluded from the trials. We aimed to compare TAVR and SAVR in terms of safety and efficacy in the population with bicuspid AS.MethodsWe conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) and observational studies, searched from PubMed, Cochrane, Scopus, and Web of Science (from inception until September 2025). Dichotomous outcomes were pooled as risk ratios (RRs), and continuous outcomes as mean differences (MDs), each with 95% confidence intervals (CIs).ResultsA total of 78,677 patients were included in one RCT, 12 retrospective cohort studies, and one prospective cohort study. TAVR, compared to SAVR, was associated with significantly higher rates of permanent pacemaker implantation (PPI) (O.R. = 2.29, 95% C.I. [1.51, 3.47], P < 0.01) and shorter length of hospital stay (M.D. = -2.24, 95% C.I. [-3.96, -0.52], P = 0.01) and lower bleeding rates (O.R. = 0.31, 95% C.I. [0.14, 0.69], P < 0.01). However, there were no significant differences in all-cause mortality (ACM) (P = 0.948), acute kidney injury (AKI) (P = 0.28), stroke incidence (P = 0.475), and vascular complications (P = 0.31). The PPI and stroke rate results were consistent during in-hospital and short-term follow-ups. However, subgroup analysis by follow-up duration revealed that long-term stroke incidence was significantly higher in the TAVI group.ConclusionTAVR offers benefit by minimizing significant bleeding and hospital length of stay. However, the benefits should be balanced against the considerably increased risk of PPI and PVL. Further RCTs are needed to confirm these findings.

Для цитирования: Gadelmawla Ahmed Farid, Mansour Ahmed, Elbataa Ahmed, Asiri Osama Hamdi, Alharbi Amnah Ali, Alquraish Fatimah Ashraf, Al-Ibrahim Fatem Saleh, AlHasani Abdulaziz Fahad, Alharbi Turki Nashi, Al Murayyi Ruba Mohammed, Alotaibi Abdulelah Ghazi, Abdul-Hafez Hamza A, Suliman Ihab. Safety and efficacy of transcatheter aortic valve replacement (TAVR) vs. surgical aortic valve replacement (SAVR) in patients with bicuspid aortic stenosis: A Systematic review and meta-analysis.. Perfusion. 2026. DOI: 10.1177/02676591261460654.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.